These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38004330)

  • 1. Angina and Non-Obstructive Coronary Artery (ANOCA) Patients with Coronary Vasomotor Disorders.
    La S; Tavella R; Wu J; Pasupathy S; Zeitz C; Worthley M; Sinhal A; Arstall M; Spertus JA; Beltrame JF
    Life (Basel); 2023 Nov; 13(11):. PubMed ID: 38004330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasomotor dysfunction in patients with angina and nonobstructive coronary artery disease is dominated by vasospasm.
    Konst RE; Damman P; Pellegrini D; Hartzema-Meijer MJ; van Uden BJC; Jansen TPJ; Brandsma J; Vart P; Gehlmann H; Maas AHEM; van Royen N; Elias-Smale SE
    Int J Cardiol; 2021 Jun; 333():14-20. PubMed ID: 33711394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal Trends of the Prevalence of Angina With No Obstructive Coronary Artery Disease (ANOCA).
    Patel S; Fung M; Liang Z; Butalia S; Anderson TJ
    Can J Cardiol; 2023 Jan; 39(1):63-70. PubMed ID: 36273723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Coronary Vasomotor Disorders in Patients With Angina and Nonobstructive Coronary Arteries: A Sydney Experience.
    Rehan R; Wong CCY; Cooke C; Weaver J; Jain P; Adams M; Ng MKC; Yong ASC
    Heart Lung Circ; 2024 Jun; ():. PubMed ID: 38925996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Diltiazem to Improve Coronary Vasomotor Dysfunction in ANOCA: The EDIT-CMD Randomized Clinical Trial.
    Jansen TPJ; Konst RE; de Vos A; Paradies V; Teerenstra S; van den Oord SCH; Dimitriu-Leen A; Maas AHEM; Smits PC; Damman P; van Royen N; Elias-Smale SE
    JACC Cardiovasc Imaging; 2022 Aug; 15(8):1473-1484. PubMed ID: 35466050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and rationale of the NetherLands registry of invasive Coronary vasomotor Function Testing (NL-CFT).
    Crooijmans C; Jansen TPJ; Konst RE; Woudstra J; Appelman Y; den Ruijter HM; Onland-Moret NC; Meeder JG; de Vos AMJ; Paradies V; Woudstra P; Sjauw KD; van 't Hof A; Meuwissen M; Winkler P; Boersma E; van de Hoef TP; Maas AHEM; Dimitriu-Leen AC; van Royen N; Elias-Smale SE; Damman P;
    Int J Cardiol; 2023 May; 379():1-8. PubMed ID: 36863419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary artery spasm and impaired myocardial perfusion in patients with ANOCA: Predictors from a multimodality study using stress CMR and acetylcholine testing.
    Pirozzolo G; Martínez Pereyra V; Hubert A; Guenther F; Sechtem U; Bekeredjian R; Mahrholdt H; Ong P; Seitz A
    Int J Cardiol; 2021 Nov; 343():5-11. PubMed ID: 34499976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of the Coronary Microvascular Angina Cardiac Magnetic Resonance Imaging (CorCMR) diagnostic study: the CorMicA CMR sub-study.
    Corcoran D; Ford TJ; Hsu LY; Chiribiri A; Orchard V; Mangion K; McEntegart M; Rocchiccioli P; Watkins S; Good R; Brooksbank K; Padmanabhan S; Sattar N; McConnachie A; Oldroyd KG; Touyz RM; Arai A; Berry C
    Open Heart; 2018; 5(2):e000924. PubMed ID: 30687508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Obstructive Sleep Apnoea (OSA) Population in the Coronary Angiogram Database of South Australia (CADOSA).
    Ooi EL; Rajendran S; Tavella R; Air T; Mahadavan G; Arstall M; Sinhal A; Worthley M; Zeitz C; Beltrame J
    Curr Probl Cardiol; 2022 Jun; 47(6):100846. PubMed ID: 33994030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis and systematic review of coronary vasospasm in ANOCA patients: Prevalence, clinical features and prognosis.
    Woudstra J; Vink CEM; Schipaanboord DJM; Eringa EC; den Ruijter HM; Feenstra RGT; Boerhout CKM; Beijk MAM; de Waard GA; Ong P; Seitz A; Sechtem U; Piek JJ; van de Hoef TP; Appelman Y
    Front Cardiovasc Med; 2023; 10():1129159. PubMed ID: 36993994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug repurposing-a promising approach for patients with angina but non-obstructive coronary artery disease (ANOCA).
    McChord J; Pereyra VM; Froebel S; Bekeredjian R; Schwab M; Ong P
    Front Cardiovasc Med; 2023; 10():1156456. PubMed ID: 37396593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Management of ANOCA, Part 1-Definition, Patient Population, and Diagnosis: JACC State-of-the-Art Review.
    Samuels BA; Shah SM; Widmer RJ; Kobayashi Y; Miner SES; Taqueti VR; Jeremias A; Albadri A; Blair JA; Kearney KE; Wei J; Park K; Barseghian El-Farra A; Holoshitz N; Janaszek KB; Kesarwani M; Lerman A; Prasad M; Quesada O; Reynolds HR; Savage MP; Smilowitz NR; Sutton NR; Sweeny JM; Toleva O; Henry TD; Moses JW; Fearon WF; Tremmel JA;
    J Am Coll Cardiol; 2023 Sep; 82(12):1245-1263. PubMed ID: 37704315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Angina and no obstruction on coronary angiography : New approaches to the diagnosis and treatment of vasomotor disorders].
    Ong P; Rudolph TK; Wiebe J; Berger R; Woitek F; Landmesser U
    Inn Med (Heidelb); 2024 May; 65(5):495-502. PubMed ID: 38517528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation Between Coronary Tortuosity and Vasomotor Dysfunction in Patients Without Obstructed Coronaries?
    Jansen TPJ; van Keeken K; Konst RE; Dimitriu-Leen A; Maas AHEM; van Royen N; Damman P; Elias-Smale S
    Front Cardiovasc Med; 2021; 8():804731. PubMed ID: 35097023
    [No Abstract]   [Full Text] [Related]  

  • 15. ANOCA patients with and without coronary vasomotor dysfunction present with limited electrocardiographic remodeling.
    Schipaanboord DJM; Jansen TPJ; Crooijmans C; Onland-Moret NC; Elias-Smale SE; Dimitriu-Leen AC; van der Harst P; van de Hoef TP; van Es R; Damman P; den Ruijter HM;
    Int J Cardiol Heart Vasc; 2024 Feb; 50():101347. PubMed ID: 38322017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex Differences in Coronary Function Test Results in Patient With Angina and Nonobstructive Disease.
    Jansen TPJ; Elias-Smale SE; van den Oord S; Gehlmann H; Dimitiriu-Leen A; Maas AHEM; Konst RE; van Royen N; Damman P
    Front Cardiovasc Med; 2021; 8():750071. PubMed ID: 34722680
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacotherapy in patients with vasomotor disorders.
    Boerhout CKM; Feenstra RGT; van de Hoef TP; Piek JJ; Beijk MAM
    Int J Cardiol Heart Vasc; 2023 Oct; 48():101267. PubMed ID: 37727753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the interplay between coronary microvascular dysfunction and mental health.
    Merdler I; Chitturi KR; Chaturvedi A; Rahman S; Cellamare M; Ozturk ST; Sawant V; Ben-Dor I; Waksman R; Hashim HD; Case BC
    Cardiovasc Revasc Med; 2024 May; ():. PubMed ID: 38789341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INOCA/ANOCA: Mechanisms and novel treatments.
    Ashokprabhu ND; Quesada O; Alvarez YR; Henry TD
    Am Heart J Plus; 2023 Jun; 30():. PubMed ID: 37377840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial single-center experience of a standardized protocol for invasive assessment of ischemia and non-obstructive coronary artery disease.
    Vaz Ferreira V; Ramos R; Castelo A; Mendonça T; Almeida-Morais L; Pereira-da-Silva T; Oliveira E; Viegas J; Garcia Brás P; Grazina A; Cacela D; Cruz Ferreira R
    Rev Port Cardiol; 2023 May; 42(5):455-465. PubMed ID: 36828182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.